Gregory J. Cost, Richmond US
Gregory J. Cost, Richmond, CA US
Patent application number | Description | Published |
---|---|---|
20130326645 | METHODS AND COMPOSITIONS FOR NUCLEASE-MEDIATED TARGETED INTEGRATION OF TRANSGENES - Disclosed herein are methods and compositions for homology-independent targeted insertion of donor molecules into the genome of a cell. | 12-05-2013 |
20140017214 | METHODS AND COMPOSITIONS FOR DELIVERY OF BIOLOGICS - Nucleases and methods of using these nucleases for genetic alteration of red blood cells (RBCs), for example for providing for a protein lacking in a monogenic disorder or a biologic for the treatment of exposure to a toxin using genetically altered RBCs. | 01-16-2014 |
20140080216 | METHODS AND COMPOSITIONS FOR TREATMENT OF A GENETIC CONDITION - Methods and compositions for a genetic disease are provided. | 03-20-2014 |
20140093913 | METHODS AND COMPOSITIONS FOR TREATMENT OF A GENETIC CONDITION - Methods and compositions for a genetic disease are provided. | 04-03-2014 |
20140273097 | METHODS AND COMPOSITIONS FOR INACTIVATING ALPHA 1,6 FUCOSYLTRANSFERASE (FUT8) GENE EXPRESSION - Disclosed herein are methods and compositions for inactivating a FUT8 gene, using fusion proteins comprising a zinc finger protein and a cleavage domain or cleavage half-domain. Polynucleotides encoding said fusion proteins are also provided, as are cells comprising said polynucleotides and fusion proteins. | 09-18-2014 |
20150056705 | METHODS AND COMPOSITIONS FOR TREATMENT OF A GENETIC CONDITION - Methods and compositions for genetic alteration of cells are provided. | 02-26-2015 |
20160024474 | METHODS AND COMPOSITIONS FOR MODULATING NUCLEASE-MEDIATED GENOME ENGINEERING IN HEMATOPOIETIC STEM CELLS - The present disclosure is in the field of genome engineering, particularly targeted modification of the genome of a hematopoietic stem cell. | 01-28-2016 |
20160030477 | GENE CORRECTION OF SCID-RELATED GENES IN HEMATOPOIETIC STEM AND PROGENITOR CELLS - The present disclosure is in the field of genome engineering, particularly targeted integration of a functional SCID-related genes (e.g., IL2RG, RAG1 and/or RAG2 gene) into the genome of a cell for provision of proteins lacking or deficient in SCID. | 02-04-2016 |